June 3 (Reuters) - Australian Clinical Labs Ltd (ACL) :
- REVISED FY21 TOTAL REVENUE GUIDANCE $657.7 - $663.3 MILLION
- ANTICIPATED THAT FY21 PRO-FORMA NPAT WILL BE 10% TO 15% HIGHER THAN FY21 FORECAST DISCLOSED IN PROSPECTUS
June 3 (Reuters) - Australian Clinical Labs Ltd (ACL) : REVISED...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.82 |
Change
-0.010(0.35%) |
Mkt cap ! $553.8M | |||
| Open | High | Low | Value | Volume |
| $2.83 | $2.83 | $2.78 | $1.879M | 670.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1071 | $2.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.83 | 2376 | 2 |
View Market Depth
| Last trade - 16.14pm 29/07/2025 (20 minute delay) ? |
| ACL (ASX) Chart |